Aguilar, Drianna O.

HRN: 21-26-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2025
CEFUROXIME 750MG (VIAL)
09/13/2025
09/20/2025
IV
410mg
Q8hours
ARTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines